UCandCrohn's.org
Sign up for CCFA's Free
E-mail Newsletter:
About CCFA
Our Mission
2010 Strategic Plan
Your Dollars at Work
Annual Report
Our Members & Partners
Press Room
Our Pharmaceutical Sponsors
Employment
Living with IBD
Information Resource Center
CCFA Community
Disease Information
How You Can Help
Research
Chapters & Events
Kids & Teens
Advocacy
Science & Professionals
Shop CCFA
Enter Keyword(s):
Google Custom Search

donate

join

find clinical trials

find physicians

corporate partners

contact us

press

site map

Accutane for Acne: Not Always the Best Medicine?

Acne isn't an exclusively teenage problem. It can afflict adults as well, and it's especially problematic among people with IBD taking steroid therapy, which can trigger or aggravate the distressing skin disorder. Isotretinoin (Accutane®) is commonly prescribed for severe acne that does not respond to other treatments.

However, the safety of isotretinoin in people with IBD has not been clearly established. There are reports of its use without any complications, but there also are anecdotal reports of patients who have experienced flare-ups of their disease while on this medication. Isotretinoin may occasionally trigger colitis-like symptoms, such as bleeding and diarrhea -- a condition called drug-induced hypersensitivity colitis. Rarely, isotretinoin has been linked to the appearance of chronic symptoms that mimic full-blown ulcerative colitis. However, there is no evidence that the medication actually causes IBD.

Potential drug interactions may occur, most notably when isotretinoin is used with 6-MP. Because of these concerns, initial therapy for acne in people with IBD should include topical treatment with cleansing agents or antibiotics, followed by oral antimicrobial agents. Isotretinoin should be used with caution and in consultation with all the physicians involved (e.g., the gastroenterologist as well as the dermatologist). Ideally, steroid-induced acne will improve by gradually tapering the steroid dose.

To learn more about treatment options for children and adolescents with IBD, please click here.

Warning: Accutane Unsafe in Pregnancy

On August 12, the FDA announced new restrictions on isotretinoin, which will strengthen already-existing safeguards intended to keep pregnant women from taking Accutane. The drug can cause severe birth defects or miscarriages.

Patients and doctors now must register with the manufacturer before using or prescribing Accutane or its generic versions.

Additionally, in light of psychiatric problems such as depression that have been linked to Accutane use, the FDA has changed its existing warnings to underscore these risks.








  • Help light fireworks in Congress! Take action over the July 4 weekend: urge your legislator to support the IBD Bill! http://bit.ly/2jh4Jk 1 day ago
Follow CCFA on Twitter